Clinical Trial Update: Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sonrotoclax plus dexamethasone with or without daratumumab in patients with t(11;14) positive primary AL amyloidosis; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Sonrotoclax

Snippet

Sponsor: Peking University People's Hospital | Conditions: AL Amyloidosis (AL), t(11;14) Positive | Phase 2 | Status: NOT_YET_RECRUITING